Aarey Drugs & Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
AAREYDRUGS
Pharmaceuticals
Share Price NSE
₹50.75
▼
-5.15 (-9.21%)
Share Price BSE
₹50.88
▼
-5.00 (-8.95%)
Track Aarey Drugs & Pharmaceuticals share price live with TickJournal's free stock screener.
Analyze Aarey Drugs & Pharmaceuticals share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Aarey Drugs & Pharmaceuticals Market Cap
₹158.50 Cr.
AAREYDRUGS P/E Ratio (TTM)
51.30
Aarey Drugs & Pharmaceuticals P/B Ratio
1.21
EPS (TTM)
₹1.42
Dividend Yield
-
Debt to Equity
0.24
AAREYDRUGS 52 Week High
₹80.49
Aarey Drugs & Pharmaceuticals 52 Week Low
₹50.75
Operating Margin
-
Profit Margin
0.99%
AAREYDRUGS Revenue (TTM)
₹405.00
EBITDA
₹13.00
Net Income
₹4.00
Total Assets
₹291.00
Total Equity
₹139.00
Aarey Drugs & Pharmaceuticals Share Price History - Stock Screener Chart
Screen AAREYDRUGS historical share price movements with interactive charts. Analyze price trends and patterns.
Aarey Drugs & Pharmaceuticals Company Profile - Fundamental Screener
Screen Aarey Drugs & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AAREYDRUGS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE198H01019
Aarey Drugs & Pharmaceuticals Balance Sheet Screener
Screen AAREYDRUGS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 291 | 303 | 291 | 245 | 233 | 194 | 146 | 170 | 143 | 125 |
| Current Assets | 266 | 283 | 271 | 219 | 218 | 181 | 133 | 157 | 130 | 117 |
| Fixed Assets | 16 | 13 | 14 | 15 | 14 | 12 | 12 | 12 | 12 | 8 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3 | 4 | 6 | 5 | 3 | 2 | 2 | 1 | 2 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 139 | 133 | 117 | 114 | 99 | 92 | 87 | 80 | 49 | 37 |
| Share Capital | 29 | 28 | 25 | 25 | 23 | 23 | 23 | 23 | 18 | 17 |
| Reserves & Surplus | 105 | 100 | 87 | 86 | 73 | 67 | 61 | 55 | 30 | 20 |
Aarey Drugs & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Aarey Drugs & Pharmaceuticals income statement and profit fundamentals.
Analyze AAREYDRUGS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aarey Drugs & Pharmaceuticals share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 405 | 484 | 403 | 422 | 495 | 355 | 307 | 359 | 353 | 399 | 249 | 216 |
| Expenses | 392 | 471 | 391 | 411 | 481 | 344 | 297 | 347 | 342 | 386 | 245 | 212 |
| EBITDA | 13 | 13 | 11 | 11 | 14 | 12 | 10 | 12 | 11 | 13 | 4 | 4 |
| Operating Profit % | 0.00% | 1.00% | 1.00% | 2.00% | 2.00% | 1.00% | 1.00% | 2.00% | 2.00% | 2.00% | 0.00% | 1.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 5 | 5 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 2 |
| Profit Before Tax | 6 | 6 | 5 | 6 | 10 | 8 | 7 | 9 | 8 | 8 | 2 | 1 |
| Tax | 2 | 2 | 1 | 2 | 4 | 2 | 1 | 2 | 2 | 3 | 1 | 0 |
| Net Profit | 4 | 4 | 5 | 4 | 7 | 7 | 6 | 7 | 6 | 6 | 1 | 1 |
| EPS | 1.20 | 1.42 | 1.84 | 1.49 | 2.72 | 2.79 | 2.48 | 2.80 | 2.64 | 3.03 | 0.77 | 0.65 |
Aarey Drugs & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen AAREYDRUGS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | -3 | -1 | 1 | 6 | 3 | 1 | -20 | 1 | 6 |
| Investing Activities | -6 | -2 | 0 | -3 | -3 | -1 | -1 | -1 | -5 | -3 |
| Financing Activities | -5 | 6 | 1 | 2 | -3 | -2 | -3 | 23 | 4 | -2 |
| Net Cash Flow | 0 | 1 | 1 | -1 | 0 | 0 | -3 | 2 | -1 | 2 |
Aarey Drugs & Pharmaceuticals Shareholding Pattern Screener
See Aarey Drugs & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Aarey Drugs & Pharmaceuticals promoter holding and ownership changes for AAREYDRUGS on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.80% | 44.80% | 44.80% | 39.06% | 45.28% | 45.28% | 45.44% | 44.80% |
| FII Holding | 2.34% | 1.97% | 1.13% | 3.86% | 3.40% | 3.40% | 2.75% | 2.34% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.79% | 46.60% | 47.01% | 45.40% | 47.14% | 44.51% | 47.56% | 44.87% |
| Other Holding | 7.07% | 6.63% | 7.06% | 11.69% | 4.18% | 6.82% | 4.25% | 7.99% |
| Shareholder Count | 16,257 | 15,796 | 14,897 | 14,063 | 16,821 | 16,179 | 16,676 | 16,288 |
Aarey Drugs & Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Aarey Drugs & Pharmaceuticals dividend history with payout and yield data.
View Aarey Drugs & Pharmaceuticals dividend details including ex-dates and amounts for AAREYDRUGS stock.
Aarey Drugs & Pharmaceuticals Stock Index Membership
See which indices include Aarey Drugs & Pharmaceuticals stock.
Check AAREYDRUGS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aarey Drugs & Pharmaceuticals Market Events Screener - Corporate Actions
Get Aarey Drugs & Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Aarey Drugs & Pharmaceuticals stock events that may affect AAREYDRUGS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.04% | ||
| Annual General Meeting | NA | 10.28% | ||
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 0.65% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.63% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.09% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 1.28% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.40% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.16% |
| 2023-12-29 | 2023-12-29 | Extraordinary General Meeting | NA | 10.77% |
| 2023-12-29 | 2023-12-29 | Annual General Meeting | NA | 10.77% |
Aarey Drugs & Pharmaceuticals Competitors Screener - Peer Comparison
Screen AAREYDRUGS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 430,345 | 39.32 | 54,729 | 9.71% | 10,980 | 56.35 |
| Divis Laboratories | 159,215 | 64.39 | 9,712 | 18.67% | 2,191 | 39.57 |
| Torrent Pharmaceuticals | 144,367 | 64.00 | 11,539 | 6.99% | 1,911 | 49.85 |
| Dr Reddys Laboratories | 106,975 | 19.68 | 33,741 | 16.73% | 5,725 | 49.71 |
| Lupin | 106,653 | 22.98 | 22,910 | 13.74% | 3,306 | 56.95 |
| Cipla | 100,349 | 22.17 | 28,410 | 7.12% | 5,291 | 34.82 |
| Zydus Life Science | 90,229 | 18.09 | 23,511 | 18.55% | 4,615 | 49.23 |
| Mankind Pharma | 84,163 | 46.25 | 12,744 | 20.90% | 2,007 | 44.70 |
| Aurobindo Pharma | 76,329 | 21.80 | 32,346 | 9.43% | 3,484 | 63.55 |
| Alkem Laboratories | 63,902 | 26.83 | 13,458 | 3.70% | 2,216 | 45.83 |
Aarey Drugs & Pharmaceuticals Company Announcements - News Screener
Screen AAREYDRUGS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-30 | Closure of Trading Window | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Board Comments On The Fine Levied By The Exchange | - |
| 2026-02-11 | Unaudited Financial Results For The Quarter Ended 31St December 2025 | - |
| 2026-02-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E 11Th February 2026. | - |
| 2026-02-04 | Board Meeting Intimation for Board Meeting Intimation | - |
| 2026-01-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-30 | Closure of Trading Window | - |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-13 | Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025 | - |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025 | - |
| 2025-11-08 | Board Meeting Intimation for Intimation Of Board Meeting. | - |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-29 | Closure of Trading Window | - |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-24 | Corrigendum To The Integrated Annual Report For FY 2024-25 | - |
| 2025-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-09-06 | Reg. 34 (1) Annual Report. | - |
| 2025-09-06 | Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2024-25 | - |